CD44 and glioblastoma: Several large-scale genomics projects on GBM specimens identified a subset of GSCs within the PZ and hypoxic zone, which are distinguished by the specific expression of CD133 (Prominin 1) and/or CD44 (Osteopontin) markers [7,8,15].